228 related articles for article (PubMed ID: 36565013)
21. Galectin-9 Alleviates LPS-Induced Preeclampsia-Like Impairment in Rats via Switching Decidual Macrophage Polarization to M2 Subtype.
Li ZH; Wang LL; Liu H; Muyayalo KP; Huang XB; Mor G; Liao AH
Front Immunol; 2018; 9():3142. PubMed ID: 30687334
[TBL] [Abstract][Full Text] [Related]
22. The Differential Expression of ERAP1/ERAP2 and Immune Cell Activation in Pre-eclampsia.
Seamon K; Kurlak LO; Warthan M; Stratikos E; Strauss JF; Mistry HD; Lee ED
Front Immunol; 2020; 11():396. PubMed ID: 32210971
[TBL] [Abstract][Full Text] [Related]
23. Immune cell profiling of preeclamptic pregnant and postpartum women by single-cell RNA sequencing.
Hu J; Guo Q; Liu C; Yu Q; Ren Y; Wu Y; Li Q; Li Y; Liu J
Int Rev Immunol; 2024; 43(1):1-12. PubMed ID: 36369864
[TBL] [Abstract][Full Text] [Related]
24. Biochemical markers in the pathogenesis of preeclampsia: novel link between placental growth factor and interleukin-6.
Negi R; Haritha V; Aziz N; Siddiqui AH
Mol Cell Biochem; 2022 Jun; 477(6):1765-1774. PubMed ID: 35292877
[TBL] [Abstract][Full Text] [Related]
25. Preeclampsia: an update.
Lambert G; Brichant JF; Hartstein G; Bonhomme V; Dewandre PY
Acta Anaesthesiol Belg; 2014; 65(4):137-49. PubMed ID: 25622379
[TBL] [Abstract][Full Text] [Related]
26. Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population.
Chaemsaithong P; Pooh RK; Zheng M; Ma R; Chaiyasit N; Tokunaka M; Shaw SW; Seshadri S; Choolani M; Wataganara T; Yeo GSH; Wright A; Leung WC; Sekizawa A; Hu Y; Naruse K; Saito S; Sahota D; Leung TY; Poon LC
Am J Obstet Gynecol; 2019 Dec; 221(6):650.e1-650.e16. PubMed ID: 31589866
[TBL] [Abstract][Full Text] [Related]
27. Identifying immune mechanisms mediating the hypertension during preeclampsia.
LaMarca B; Cornelius DC; Harmon AC; Amaral LM; Cunningham MW; Faulkner JL; Wallace K
Am J Physiol Regul Integr Comp Physiol; 2016 Jul; 311(1):R1-9. PubMed ID: 27097659
[TBL] [Abstract][Full Text] [Related]
28. Placental morphometry in hypertensive disorders of pregnancy and its relationship with birth weight in a Latin American population.
Marques MR; Grandi C; Nascente LMP; Cavalli RC; Cardoso VC
Pregnancy Hypertens; 2018 Jul; 13():235-241. PubMed ID: 30177058
[TBL] [Abstract][Full Text] [Related]
29. Chronic hypertension and superimposed preeclampsia: screening and diagnosis.
Kametas NA; Nzelu D; Nicolaides KH
Am J Obstet Gynecol; 2022 Feb; 226(2S):S1182-S1195. PubMed ID: 35177217
[TBL] [Abstract][Full Text] [Related]
30. Hypothesis: selective phosphodiesterase-5 inhibition improves outcome in preeclampsia.
Downing JW; Ramasubramanian R; Johnson RF; Minzter BH; Paschall RL; Sundell HW; Engelhardt B; Lewis R
Med Hypotheses; 2004; 63(6):1057-64. PubMed ID: 15504576
[TBL] [Abstract][Full Text] [Related]
31. An integrated model of preeclampsia: a multifaceted syndrome of the maternal cardiovascular-placental-fetal array.
Yagel S; Cohen SM; Goldman-Wohl D
Am J Obstet Gynecol; 2022 Feb; 226(2S):S963-S972. PubMed ID: 33712272
[TBL] [Abstract][Full Text] [Related]
32. Hypertension in pregnancy: Taking cues from pathophysiology for clinical practice.
Sava RI; March KL; Pepine CJ
Clin Cardiol; 2018 Feb; 41(2):220-227. PubMed ID: 29485737
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia.
Possomato-Vieira JS; Khalil RA
Adv Pharmacol; 2016; 77():361-431. PubMed ID: 27451103
[TBL] [Abstract][Full Text] [Related]
34. Ophthalmic artery Doppler at 19-23 weeks' gestation in pregnancies that deliver small-for-gestational-age neonates.
Abdel Azim S; Wright A; Sapantzoglou I; Nicolaides KH; Charakida M
Ultrasound Obstet Gynecol; 2022 Jul; 60(1):52-58. PubMed ID: 35441758
[TBL] [Abstract][Full Text] [Related]
35. Impact of Hypertension and Preeclampsia Intervention Trial At Near Term-I (HYPITAT-I) on obstetric management and outcome in The Netherlands.
de Sonnaville CMW; Hukkelhoven CW; Vlemmix F; Groen H; Schutte JM; Mol BW; van Pampus MG
Ultrasound Obstet Gynecol; 2020 Jan; 55(1):58-67. PubMed ID: 31486156
[TBL] [Abstract][Full Text] [Related]
36. Regulatory T Cell Apoptosis during Preeclampsia May Be Prevented by Gal-2.
Meister S; Hahn L; Beyer S; Mannewitz M; Perleberg C; Schnell K; Anz D; Corradini S; Schmoeckel E; Mayr D; Hasbargen U; Zati Zehni A; Mahner S; Jeschke U; Kolben T
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163802
[TBL] [Abstract][Full Text] [Related]
37. Should angiogenic markers be included in diagnostic criteria of superimposed pre-eclampsia in women with chronic hypertension?
Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
Ultrasound Obstet Gynecol; 2022 Feb; 59(2):192-201. PubMed ID: 34165863
[TBL] [Abstract][Full Text] [Related]
38. Pathogenesis of Preeclampsia and Therapeutic Approaches Targeting the Placenta.
Jena MK; Sharma NR; Petitt M; Maulik D; Nayak NR
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32599856
[TBL] [Abstract][Full Text] [Related]
39. Progress in the understanding of the pathophysiology of immunologic maladaptation related to early-onset preeclampsia and metabolic syndrome related to late-onset preeclampsia.
Robillard PY; Dekker G; Scioscia M; Saito S
Am J Obstet Gynecol; 2022 Feb; 226(2S):S867-S875. PubMed ID: 35177223
[TBL] [Abstract][Full Text] [Related]
40. Review of the immune mechanisms of preeclampsia and the potential of immune modulating therapy.
Collier AY; Smith LA; Karumanchi SA
Hum Immunol; 2021 May; 82(5):362-370. PubMed ID: 33551128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
